Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial

Study limitation reported by the research below: “Non-inferiority was narrowly missed (upper CI bound 1.53 vs. threshold 1.25), but underpowering means the true comparative efficacy remains uncertain.”